Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01725750 · ClinicalTrials.gov registry record · NA
Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01725750 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 88 participants.
The verdict
NCT01725750, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study aims to evaluate the efficacy of 4 weeks of daily light exposure in reducing Post-Traumatic Brain Injury (TBI) Fatigue immediately post-treatment and at a one-month follow up. The investigators hypothesize that individuals receiving 4 weeks of bright white light treatment will report significant reductions in fatigue compared to individuals receiving dim red light treatment for the same duration of time, and that these treatment effects will be maintained one month after treatment completion.
Interventions
- DEVICE Bright White Light (BWL)
- DEVICE Dim Red Light (DRL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01725750
The ClinicalTrials.gov registry entry for NCT01725750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bright White Light (BWL) is the first listed.
NCT01725750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01725750 about?
NCT01725750 is a clinical study titled "Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy". This study aims to evaluate the efficacy of 4 weeks of daily light exposure in reducing Post-Traumatic Brain Injury (TBI) Fatigue immediately post-treatment and at a one-month follow up. The investigators hypothesize that individuals receiving 4 weeks of bright white light treatment will report sign...
What is the current status of trial NCT01725750?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2012-11. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01725750?
The interventions under investigation include: Bright White Light (BWL) (DEVICE), Dim Red Light (DRL) (DEVICE).
Who is sponsoring clinical trial NCT01725750?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.